Upon KI treatment, MAP3K8 inhibition significantly reduced both cell migration (Fig. 2c, left panels) and cell invasion (Fig. 2c, right panels), in the two human ovarian cancer cell lines tested. The gene discussed is MAP3K8; the disease is ovarian cancer.